February 13, 2020 / 10:43 PM / 11 days ago

BRIEF-VistaGen Therapeutics Reports Q3 Loss Per Share $0.15

Feb 13 (Reuters) - VistaGen Therapeutics Inc:

* VISTAGEN THERAPEUTICS REPORTS FISCAL 2020 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES CNS PIPELINE OVERVIEW

* VISTAGEN THERAPEUTICS INC QTRLY LOSS PER SHARE $0.15 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below